ArticlePharmaceuticals (Basel, Switzerland)2024

EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation.

Michela Campolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.